Clinical Trial Update: A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating selinexor in Wilms tumor, rhabdoid tumors, and other solid tumors is currently recruiting at Memorial Sloan Kettering Cancer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Peripheral Nerve Sheath Tumor
• Rhabdoid Tumor
• Solid Tumor
• Wilms Tumor

Drugs mentioned

• XPOVIO (selinexor)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Wilms Tumor, Rhabdoid Tumor | Phase 2 | Status: RECRUITING